Novick A C
Department of Urology, Cleveland Clinic Foundation, Ohio.
Urol Clin North Am. 1993 May;20(2):277-82.
The role of nephron-sparing surgery for renal cell carcinoma is evolving, and continued careful evaluation of patient outcome data is needed to define appropriate limits for this approach. Both accepted and controversial aspects of this approach are reviewed in this article.
保留肾单位手术在肾细胞癌治疗中的作用正在不断演变,需要持续仔细评估患者的预后数据,以确定该方法的合适应用范围。本文将对该方法已被认可和存在争议的方面进行综述。